Christopher Garabedian
2015
In 2015, Christopher Garabedian earned a total compensation of $4.5M as Former President and Chief Executive Officer at Sarepta Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Option Awards | $3,878,006 |
|---|---|
| Salary | $152,559 |
| Other | $479,841 |
| Total | $4,510,407 |
Garabedian received $3.9M in option awards, accounting for 86% of the total pay in 2015.
Garabedian also received $152.6K in salary and $479.8K in other compensation.
Rankings
In 2015, Christopher Garabedian's compensation ranked 1,848th out of 13,638 executives tracked by ExecPay. In other words, Garabedian earned more than 86.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,848 out of 13,638 | 86th |
Division Manufacturing | 669 out of 5,187 | 87th |
Major group Chemicals And Allied Products | 243 out of 1,857 | 87th |
Industry group Drugs | 189 out of 1,531 | 88th |
Industry Pharmaceutical Preparations | 152 out of 1,179 | 87th |
Source: SEC filing on May 31, 2016.
Garabedian's colleagues
We found four more compensation records of executives who worked with Christopher Garabedian at Sarepta Therapeutics in 2015.